235 related articles for article (PubMed ID: 17124083)
1. Bisphosphonate complications including osteonecrosis of the jaw.
Mehrotra B; Ruggiero S
Hematology Am Soc Hematol Educ Program; 2006; ():356-60, 515. PubMed ID: 17124083
[TBL] [Abstract][Full Text] [Related]
2. The incidence of jaw osteonecrosis in multiple myeloma patients treated with bisphosphonates.
Kraj M; Pogłód R; Maj S; Owczarska K
Acta Pol Pharm; 2006; 63(5):450-2. PubMed ID: 17357613
[No Abstract] [Full Text] [Related]
3. Bisphosphonate-induced osteonecrosis of the jaw: long-term outcomes.
Katz J; George T; Sandow P; Machado M; Dickerson L; Moreb JS
J Support Oncol; 2009; 7(1):9-10. PubMed ID: 19278171
[No Abstract] [Full Text] [Related]
4. [Osteonecrosis associated with the use of biphosphonates: Case report].
Anguita C T; Agurto P J; Roa E I; Laissle C G
Rev Med Chil; 2006 Sep; 134(9):1161-5. PubMed ID: 17171218
[TBL] [Abstract][Full Text] [Related]
5. [Bisphosphonates and osteonecrosis of the jaws in patients with myelomatosis].
Neumann B; Gregersen H
Ugeskr Laeger; 2006 May; 168(21):2078-9. PubMed ID: 16768928
[TBL] [Abstract][Full Text] [Related]
6. Why osteonecrosis of the jaw after bisphosphonates treatment is more frequent in multiple myeloma than in solid tumors.
Delibasi T; Altundag K; Kanlioglu Y
J Oral Maxillofac Surg; 2006 Jun; 64(6):995-6. PubMed ID: 16713825
[No Abstract] [Full Text] [Related]
7. Bisphosphonate-related osteonecrosis of the jaw: background and guidelines for diagnosis, staging and management.
Ruggiero SL; Fantasia J; Carlson E
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2006 Oct; 102(4):433-41. PubMed ID: 16997108
[No Abstract] [Full Text] [Related]
8. Osteonecrosis of the jaw in cancer patients receiving IV bisphosphonates.
Van Poznak C; Estilo C
Oncology (Williston Park); 2006 Aug; 20(9):1053-62; discussion 1065-6. PubMed ID: 16986349
[TBL] [Abstract][Full Text] [Related]
9. Nonexposed variant of bisphosphonate-associated osteonecrosis of the jaw: a case series.
Fedele S; Porter SR; D'Aiuto F; Aljohani S; Vescovi P; Manfredi M; Arduino PG; Broccoletti R; Musciotto A; Di Fede O; Lazarovici TS; Campisi G; Yarom N
Am J Med; 2010 Nov; 123(11):1060-4. PubMed ID: 20851366
[TBL] [Abstract][Full Text] [Related]
10. Bisphosphonate-associated osteonecrosis of the jaws: a therapeutic dilemma.
Diego R; D'Orto O; Pagani D; Agazzi A; Marzano U; Derada Troletti G; Fontanella W; Pignataro L
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2007 Mar; 103(3):e1-5. PubMed ID: 17197204
[TBL] [Abstract][Full Text] [Related]
11. Incidence of osteonecrosis of the jaw in patients with multiple myeloma and breast or prostate cancer on intravenous bisphosphonate therapy.
Wang EP; Kaban LB; Strewler GJ; Raje N; Troulis MJ
J Oral Maxillofac Surg; 2007 Jul; 65(7):1328-31. PubMed ID: 17577497
[TBL] [Abstract][Full Text] [Related]
12. Bisphosphonate-related osteonecrosis: genetic and acquired risk factors.
Sarasquete ME; González M; San Miguel JF; García-Sanz R
Oral Dis; 2009 Sep; 15(6):382-7. PubMed ID: 19413677
[TBL] [Abstract][Full Text] [Related]
13. American Association of Oral and Maxillofacial Surgeons position paper on bisphosphonate-related osteonecrosis of the jaws--2009 update.
Ruggiero SL; Dodson TB; Assael LA; Landesberg R; Marx RE; Mehrotra B;
J Oral Maxillofac Surg; 2009 May; 67(5 Suppl):2-12. PubMed ID: 19371809
[No Abstract] [Full Text] [Related]
14. [Relationship between osteonecrosis of the jaw and bisphosphonate treatment].
Badel T; Keros J; Krapac L; Pavicin IS
Arh Hig Rada Toksikol; 2010 Sep; 61(3):371-80. PubMed ID: 20860977
[TBL] [Abstract][Full Text] [Related]
15. Bisphosphonate-associated osteonecrosis of the jaw: conclusions based on an analysis of case series.
Landesberg R; Wilson T; Grbic JT
Dent Today; 2006 Aug; 25(8):52, 54-7. PubMed ID: 16925161
[TBL] [Abstract][Full Text] [Related]
16. Osteonecrosis of the jaws in patients treated with intravenous bisphosphonates (BRONJ): A concise update.
Bagan J; Scully C; Sabater V; Jimenez Y
Oral Oncol; 2009 Jul; 45(7):551-4. PubMed ID: 19251474
[TBL] [Abstract][Full Text] [Related]
17. [Multiple myeloma].
Abe M
Nihon Rinsho; 2009 May; 67(5):991-5. PubMed ID: 19432122
[TBL] [Abstract][Full Text] [Related]
18. Osteonecrosis of the jaws and bisphosphonate therapy.
Ruggiero SL; Drew SJ
J Dent Res; 2007 Nov; 86(11):1013-21. PubMed ID: 17959890
[TBL] [Abstract][Full Text] [Related]
19. Intravenous bisphosphonate-associated osteonecrosis of the jaw.
Statz TA; Guthmiller JM; Humbert LA; Johnson GK
J Periodontol; 2007 Nov; 78(11):2203-8. PubMed ID: 17970689
[TBL] [Abstract][Full Text] [Related]
20. Bisphosphonate-associated osteonecrosis of the jaw in patients with multiple myeloma and breast cancer.
Nastro E; Musolino C; Allegra A; Oteri G; Cicciù M; Alonci A; Quartarone E; Alati C; De Ponte FS
Acta Haematol; 2007; 117(3):181-7. PubMed ID: 17164581
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
